AGP Picks
View all

Harrisburg Wellness Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.

Press releases published on October 28, 2026

CodaPet expands compassionate in-home pet euthanasia services in Philadelphia, PA
ALEX’S LEMONADE STAND FOUNDATION SURPASSES $400 MILLION RAISED FOR CHILDHOOD CANCER RESEARCH
Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy
Bottled water continues to rank the highest among  Americans’ most preferred beverages
Precipio Announces Q3-2026 Shareholder Update Call
DBV Technologies Reports Third Quarter 2026 Financial Results and Business Update
 DBV Technologies publie ses résultats financiers du troisième trimestre 2026 et fait le point sur ses activités
LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession
STERIS Announces Dividend of $0.69 per share
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Relay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026
Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026
Jushi Holdings Inc. Reports Third Quarter 2026 Financial Results
Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology
Teladoc Health Reports Third Quarter 2026 Results
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and  Path to Advance Development
MIMEDX Announces Third Quarter 2026 Operating & Financial Results
Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Harrisburg Wellness Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.